Control of cell cycle progression by c-Jun is p53 dependent

Genes and Development

Volumn 13, Issue 5, 1999, Pages 607-619

  Schreiber, Martin ^a,d   Kolbus, Andrea ^b   Piu, Fabrice ^c,e   Szabowski, Axel ^b   Möhle Steinlein, Uta ^a   Tian, Jianmin ^c   Karin, Michael ^c   Angel, Peter ^b   Wagner, Erwin F ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Vienna Biocenter   (Austria)

^e ACADIA PHARMACEUTICALS INC   (United States)

Author keywords

C Jun; Cell cycle regulation; Cell proliferation; Mouse knockout fibroblasts; P53

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; GROWTH REGULATION; KNOCKOUT MOUSE; MITOGENESIS; MOUSE; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0033104956     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.5.607     Document Type: Article

References (64)

1. Agarwal, M.L., A. Agarwal, W.R. Taylor, and G.R. Stark. 1995. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. 92: 8493-8497.
2. Angel, P. and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072: 129-157.
3. Angel, P., M. Imagawa, R. Chiu, B. Stein, R.J. Imbra, H.J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49: 729-739.
4. Bates, S. and K.H. Vousden. 1996. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6: 12-19.
5. 1 cyclin complexes. Genes & Dev. 9: 1340-1353.
6. Bengal, E., L. Ransone, R. Scharfmann, V.J. Dwarki, S.J. Tapscott, H. Weintraub, and I.M. Verma. 1992. Functional antagonism between c-Jun and MyoD proteins: Direct physical association. Cell 68: 507-519.
7. Bohmann, D., M.C. Ellis, L.M. Staszewski, and M. Mlodzik. 1994. Drosophila Jun mediates Ras-dependent photoreceptor determination. Cell 78: 973-986.
8. Bossy-Wetzel, E., L. Bakiri, and M. Yaniv. 1997. Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16: 1695-1709.
9. Brüsselbach, S., U. Möhle-Steinlein, Z.-Q. Wang, M. Schreiber, F.C. Lucibello, R. Müller, and E.F. Wagner. 1995. Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. Oncogene 10: 79-86.
10. Bushel, P., J.H. Kim, W. Chang, J.J. Catino, H.E. Ruley, and C.C. Kumar. 1995. Two serum response elements mediate transcriptional repression of human smooth muscle alpha-actin promoter in ras-transformed cells. Oncogene 10: 1361-1370.
11. Cano, E. and L.C. Mahadevan. 1995. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20: 117-122.
12. De Cesare, D., D. Vallone, A. Caracciolo, P. Sassone-Corsi, C. Nerlov, and P. Verde. 1995. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene 11: 365-376.
13. Deng, T. and M. Karin. 1993. JunB differs from c-Jun in its DNA binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes & Dev. 7: 479-490.
14. Downward, J. 1997. Cell cycle: Routine role for Ras. Curr. Biol. 7: R258-260.
15. Elledge, S.J., J. Winston, and J.W. Harper. 1996. A question of balance: The role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol. 6: 388-392.
16. Ginsberg, D., M. Oren, M. Yaniv, and J. Piette 1990. Protein-binding elements in the promoter region of the mouse p53 gene. Oncogene 5: 1285-1290.
17. Grana, X. and E.P. Reddy. 1995. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11: 211-219.
18. Greenhalgh, D.A., X.J. Wang, J.N. Eckardt, and D.R. Roop. 1995. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: Association of v-fos expression with promotion and tumor autonomy. Cell Growth Differ. 6: 579-586.
19. Gruda, M.C., J. van Amsterdam, C.A. Rizzo, S.K. Durham, S. Lira, and R. Bravo. 1996. Expression of FosB during mouse development: Normal development of FosB knockout mice. Oncogene 12: 2177-2185.
20. Ham, J., C. Babij, J. Whitfield, C.M. Pfarr, D. Lallemand, M. Yaniv, and L.L. Rubin. 1995. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14: 927-939.
21. Harper, J.W. and S.J. Elledge. 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6: 56-64.
22. Harvey, M., A.T. Sands, R.S. Weiss, M.E. Hegi, R.W. Wiseman, P. Pantazis, B.C. Giovanella, M.A. Tainsky, A. Bradley, and L.A. Donehower. 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8: 2457-2467.
23. Herber, B., M. Truss, M. Beato, and R. Müller. 1994. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9: 2105-2107.
24. Herrera, R.E., V. Sah, B.O. Williams, T.P. Makela, R.A. Weinberg, and T. Jacks. 1996. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell Biol. 16: 2402-2407.
25. Hicks, G.G., S.E. Egan, A.H. Greenberg, and M. Mowat. 1991. Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arest. Mol. Cell. Biol. 11: 1344-1352.
26. Hilberg, F. and E.F. Wagner. 1992. Embryonic stem (ES) cells lacking functional c-jun: Consequences for growth and differentiation, AP-1 activity and tumorigenicity. Oncogene 7: 2371-2380.
27. Hilberg, F., A. Aguzzi, N. Howells, and E.F. Wagner. 1993. c-jun is essential for normal mouse development and hepatogenesis. Nature 365: 179-181.
28. Jacks, T. and R.A. Weinberg. 1996. Cell-cycle control and its watchman. Nature 381: 643-644.
29. Jacks, T., L. Remington, B.O. Williams, E.M. Schmitt, S. Halachmi, R.T. Bronson, and R.A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7.
30. Johnson, R.S., B. van Lingen, V.E. Papaioannou, and B.M. Spiegelman. 1993. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes & Dev. 7: 1309-1317.
31. Johnson, R., B. Spiegelman, D. Hanahan, and R. Wisdom. 1996. Cellular transformation and malignancy induced by ras require c-jun. Mol. Cell. Biol. 16: 4504-4511.
32. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270: 16483-16486.
33. Karin, M. and T. Hunter. 1995. Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus. Curr. Biol. 5: 747-757.
34. Kovary, K. and R. Bravo. 1991. The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11: 4466-4472.
35. Lee, H.H., W.H. Chiang, S.H. Chiang, Y.C. Liu, J. Hwang, and S.Y. Ng. 1995. Regulation of cyclin D1, DNA topoisomerase I, and proliferating cell nuclear antigen promoters during the cell cycle. Gene Expr. 4: 95-109.
36. Levine, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
37. Li, L., J.C. Chambard, M. Karin, and E.N. Olson. 1992. Fos and Jun repress transcriptional activation by myogenin and MyoD: The amino terminus of Jun can mediate repression. Genes & Dev. 6: 676-689.
38. Li, R., S. Waga, G.J. Hannon, D. Beach, and B. Stillman. 1994. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537.
39. Lord, K.A., A. Abdollahi, B. Hoffman-Lieberman, and D.A. Liebermann. 1993. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol. Cell. Biol. 13: 841-851.
40. Macleod, K.F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes & Dev. 9: 935-944.
41. Maltzman, W. and L. Czyzyk. 1984. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4: 1689-1694.
42. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066-2076.
43. Midgley, C.A. and D. Lane. 1997. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15: 1179-1189.
44. Murphy, C., D. Nikodem, K. Howcroft, J.D. Weissman, and D.S. Singer. 1996. Active repression of major histocompatibility complex class I genes in a human neuroblastoma cell line. J. Biol. Chem. 271: 30992-30999.
45. Patel, H.R. and A.J. Sytkowski. 1995. Erythropoietin activation of AP1 (Fos/Jun). Exp. Hematol. 23: 619-625.
46. Pfarr, C.M., F. Mechta, G. Spyrou, D. Lallemand, S. Carillo, and M. Yaniv. 1994. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76: 747-760.
47. Riahowol, K., J. Schiff, and M.Z. Gilman. 1992. Transcription factor AP-1 is required for initiation of DNA synthesis and is lost during cellular aging. Proc. Natl. Acad. Sci. 89: 157-161.
48. Sabapathy, K., M. Klemm, R. Jacnisch, and E.F. Wagner. 1997. Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J. 16: 6217-6229.
49. Schorpp, M., A.-G. Mattei, I. Herr, S. Gack, J. Schaper, and P. Angel. 1995. Structural organization and chromosomal localization of the mouse collagenase type I gene. Biochem. J. 308: 211-217.
50. Schreiber, M., B. Baumann, M. Cotten, P. Angel, and E.F. Wagner. 1995. Fos is an essential component of the mammalian UV response. EMBO J. 14: 5338-5349.
51. Sherr, C.J. 1994. G1 phase progression: Cycling on cue. Cell 79: 551-555.
52. _. 1996. Cancer cell cycles. Science 274: 1672-1677.
53. 1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
54. Smeal, T., B. Binetruy, D.A. Mercola, M. Birrer, and M. Karin. 1991. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354: 494-496.
55. Smith, M.J. and E.V. Prochownik. 1992. Inhibition of c-jun causes reversible proliferative arrest and withdrawal from the cell cycle. Blood 79: 2107-2115.
56. Suzuki, T., H. Okuno, T. Yoshida, T. Endo, H. Nishina, and H. Iba. 1991. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucl. Acids Res. 25: 5537-5542.
57. Szabo, E., L.H. Preis, and M.J. Birrer. 1994. Constitutive c-Jun expression induces partial macrophage differentiation in U-937 cells. Cell Growth Differ. 5: 439-446.
58. Todaro, G.J. and H. Green. 1963. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17: 299-313.
59. Verheij, M., R. Bose, X.H. Lin, B. Yao, W.D. Jarvis, S. Grant, M.J. Birrer, E. Szabo, L.I. Zon, J.M. Kyriakis, A. Haimovitz-Friedmann, Z. Fuks, and R.N. Kolesnick. 1996. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380: 75-79.
60. Wang, Z.-Q., J. Liang, K. Schellander, E.F. Wagner, and A.E. Grigoriadis. 1995. c-Fos induced osteosarcoma formation in transgenic mice: Cooperativity with c-Jun and the role of endogenous c-Fos. Cancer Res. 55: 6244-6251.
61. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
62. _. 1996. E2F and cell proliferation: A world turned upside down. Cell 85: 457-459.
63. Yoshioka, K., T. Deng, M. Cavigelli, and M. Karin. 1995. Antitumor promotion by phenolic antioxidants: Inhibition of AP-1 activity through induction of Fra expression. Proc. Natl. Acad. Sci. 92: 4972-4976.
64. Zetterberg, A., O. Larsson, and K.G. Wiman. 1995. What is the restriction point? Curr. Opin. Cell Biol. 7: 835-842.